FDA Presses Pause On Trial For OTC Version Of Anti-impotence Drug Cialis
ibtimes.com
news
2022-05-30 05:50:58

Sanofi logo at the company's headquarters during the annual results news conference in Paris, France, February 4, 2022. Photo: Reuters / BENOIT TESSIER The U.S. health regulator has put on hold a trial designed to evaluate switching the prescription-only erectile dysfunction drug Cialis to an over-the-counter (OTC) treatment, French drugmaker Sanofi said on Monday.The pause is related to concerns about how the trial protocol has been designed, the company said, adding that no patients had so far been recruited for the study.
